EUROAPI
Paris, France
Program data pending ClinicalTrials.gov matching
60.0
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (10)
○ EMA GMP
○ MHRA GMP
Quick Facts: EUROAPI
- Signal Score
- 60.0/100
- Quality Compliance
- Assessment pending
- Headquarters
- Paris, France
- Modalities
- Prostaglandin API, Small Molecule API, Steroids/Hormones, Peptides, Oligonucleotides, Microbial Fermentation
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesProstaglandin API, Small Molecule API, Steroids/Hormones, Peptides, Oligonucleotides, Microbial Fermentation
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
60.0
Broad modality coverage (6 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Recent Press10 articles
Broad modality coverage (6 modalities)
Recent News 10 articles
Particle Dynamics melds with former EuroAPI plant to debut new CDMO Codis - Fierce Pharma
Frédéric Robert appointed EUROAPI’s Chief Commercial Officer overseeing API Solutions and CDMO activities - Yahoo Finance
EUROAPI to Acquire BianoGMP for €10M - Contract Pharma
EuroAPI sheds UK facility as restructuring plan rolls on - Fierce Pharma
Euroapi Announces Restructuring Plan - DCAT Value Chain Insights
Euroapi, Sanofi’s Spinout CDMO Details Restructuring Plan, Including Mfg - DCAT Value Chain Insights
EUROAPI Enhances Its CDMO Capabilities Through a Pivotal Collaboration With SpiroChem, a Leading Contract Research Organization (CRO) - Business Wire
Sanofi’s Euroapi Launches as Stand-alone $1-Bn CDMO - DCAT Value Chain Insights
EuroAPI is ready to emerge from Sanofi’s shadow - C&EN
In cutting sales guidance, EuroAPI cites CDMO industry struggles and customers' inventory reductions - Fierce Pharma
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Cayman Chemical / Cayman Pharma s.r.o.
Ann Arbor, MI (Cayman Chemical) / Neratovice, Czech Republic (Cayman Pharma)
Prostaglandin API, Small Molecule API, Psychedelic APIs, Cationic Lipids, Biochemicals
Cytovance Biologics
Oklahoma City, OK
Signal Score: 61.5
Microbial Fermentation, Biologics, Recombinant Proteins, Mammalian Cell Culture, Plasmid DNA